This clinical-stage biotech develops therapies for serious immunological diseases, with a focus on late-stage biologic candidates.
MXene nanosheet-based catalytic membranes efficiently degrade antibiotics in pharmaceutical wastewater while reducing ...
Dozens of biotechs reported earnings this week. BioSpace recaps key highlights from Capricor Therapeutics, Legend Biotech, ...
CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported fourth-quarter earnings of $52.7 million. On a per-share basis, the Coral Gables, ...
Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total RevenuesQ4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results